Allmed Medical Products Co.,Ltd (SHE:002950)

SHE:002950 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	585.16	397.04	522.2	678.46	1,302
Short-Term Investments	-	-	-	-	200
Trading Asset Securities	83.15	96.82	264.63	8.14	35.63
Cash & Short-Term Investments	668.32	493.86	786.84	686.6	1,538
Cash Growth	35.33%	-37.23%	14.60%	-55.35%	531.34%
Accounts Receivable	482.75	391.25	521.56	532.46	295.55
Other Receivables	42.18	70.15	47.38	56.58	51.75
Receivables	524.93	461.4	568.94	589.04	347.3
Inventory	615.27	707.21	877.33	846.63	707.28
Other Current Assets	119.29	117.08	165.85	120.83	243.85
Total Current Assets	1,928	1,780	2,399	2,243	2,836
Property, Plant & Equipment	1,829	1,987	2,019	1,603	1,259
Long-Term Investments	898.22	854.89	824.79	758.68	403.24
Goodwill	95.3	98.09	98.09	25.99	-
Other Intangible Assets	182.78	202.66	213.58	234.75	219.53
Long-Term Accounts Receivable	-	-	-	17.05	18.76
Long-Term Deferred Tax Assets	49.14	56.19	48.88	64	44.14
Long-Term Deferred Charges	6.76	7.08	4.74	1.14	1.26
Other Long-Term Assets	69.54	98.86	139.79	57.01	68.85
Total Assets	5,059	5,084	5,748	5,005	4,856
Accounts Payable	360.87	326.1	897.32	253.86	143.87
Accrued Expenses	82.48	76.39	84.96	79.82	73.7
Short-Term Debt	494.31	749.57	792.09	1,060	1,086
Current Portion of Long-Term Debt	76.78	54.2	27.15	99.09	-
Current Portion of Leases	-	6.36	2.1	2.27	-
Current Income Taxes Payable	33.66	6.29	4.93	35.28	85.78
Current Unearned Revenue	13.02	64.84	129.32	7.8	52.48
Other Current Liabilities	46.61	41.7	129.06	100.91	23.44
Total Current Liabilities	1,108	1,325	2,067	1,639	1,465
Long-Term Debt	89.17	146.32	111.41	127.61	100
Long-Term Leases	0.43	7.18	5.37	0.6	-
Long-Term Unearned Revenue	197.51	191.94	189.68	292.17	220.45
Long-Term Deferred Tax Liabilities	216.04	199.71	243.16	193.82	147.28
Other Long-Term Liabilities	-	2.75	-	-	-
Total Liabilities	1,611	1,873	2,617	2,253	1,933
Common Stock	633.27	633.27	633.27	633.27	633.27
Additional Paid-In Capital	580.21	565.77	565.77	564.49	572.56
Retained Earnings	2,312	1,960	1,888	1,619	1,745
Treasury Stock	-97.89	-	-	-	-
Comprehensive Income & Other	8.96	28.1	14.32	-63.63	-40.15
Total Common Equity	3,437	3,187	3,101	2,753	2,911
Minority Interest	11.51	23.73	29.91	-0.91	12.41
Shareholders' Equity	3,448	3,211	3,131	2,752	2,923
Total Liabilities & Equity	5,059	5,084	5,748	5,005	4,856
Total Debt	660.7	963.64	938.13	1,289	1,186
Net Cash (Debt)	7.62	-469.78	-151.29	-602.53	351.86
Net Cash Per Share	0.01	-0.74	-0.24	-0.95	0.56
Filing Date Shares Outstanding	620.67	621.92	633.27	633.27	633.27
Total Common Shares Outstanding	620.67	633.27	633.27	633.27	633.27
Working Capital	820.08	454.08	332.03	604.51	1,371
Book Value Per Share	5.54	5.03	4.90	4.35	4.60
Tangible Book Value	3,158	2,886	2,789	2,492	2,691
Tangible Book Value Per Share	5.09	4.56	4.40	3.94	4.25
Buildings	-	1,220	1,044	989.99	814.48
Machinery	-	2,044	1,679	1,534	1,120
Construction In Progress	-	18.35	400.62	38.24	72.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.